» Articles » PMID: 33940001

Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians

Overview
Journal Am J Med
Specialty General Medicine
Date 2021 May 3
PMID 33940001
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.

Terrier J, Abouir K, Gaspar F, Daali Y, Samer C Clin Pharmacol Ther. 2024; 117(2):554-560.

PMID: 39535447 PMC: 11739736. DOI: 10.1002/cpt.3491.


Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland.

Coumau C, Gaspar F, Terrier J, Schulthess-Lisibach A, Lutters M, Le Pogam M Front Pharmacol. 2024; 15:1332147.

PMID: 38633615 PMC: 11022661. DOI: 10.3389/fphar.2024.1332147.


Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy.

Ma Y, Song Z, Li X, Jiang D, Zhao R, Yi Z Clin Pharmacokinet. 2024; 63(3):279-291.

PMID: 38460105 DOI: 10.1007/s40262-024-01358-3.


Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.

Gaspar F, Terrier J, Favre S, Gosselin P, Fontana P, Daali Y CPT Pharmacometrics Syst Pharmacol. 2023; 12(10):1541-1552.

PMID: 37723920 PMC: 10583248. DOI: 10.1002/psp4.13032.


Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches.

Ahmad I, Kuznetsov A, Pirzada A, Alsharif K, Daglia M, Khan H Front Chem. 2023; 11:1145974.

PMID: 37123881 PMC: 10133580. DOI: 10.3389/fchem.2023.1145974.